Raleigh-Durham

Raleigh-Durham's Research Triangle is one of America's premier innovation hubs, driving M&A activity across biotech, pharmaceuticals, and enterprise software, with over 300 life sciences companies clustered near Research Triangle Park. The presence of Duke, UNC, and NC State creates a continuous pipeline of technology spinoffs and academic research commercialization, supported by specialized investors like QHP Capital and Hatteras Venture Partners. The Triangle ranks among the top five U.S. biotech hubs and has emerged as a seller's market, with national PE firms and strategics competing aggressively for quality biotech and SaaS assets. Rapid population growth - roughly double the national rate over the past decade - has also fueled healthcare services consolidation and a sustained wave of business formation-driven deal flow across the broader middle market.

---